DD263231A5 - Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes - Google Patents

Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes Download PDF

Info

Publication number
DD263231A5
DD263231A5 DD87301670A DD30167087A DD263231A5 DD 263231 A5 DD263231 A5 DD 263231A5 DD 87301670 A DD87301670 A DD 87301670A DD 30167087 A DD30167087 A DD 30167087A DD 263231 A5 DD263231 A5 DD 263231A5
Authority
DD
German Democratic Republic
Prior art keywords
solubilizer
nonionic
castor oil
polyethoxylated
drug
Prior art date
Application number
DD87301670A
Other languages
German (de)
English (en)
Inventor
Karl-Erik L Falk
Sven M Hugosson
Adam Rosinski
John A Sjoegren
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20364135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD263231(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD263231A5 publication Critical patent/DD263231A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD87301670A 1986-04-11 1987-04-09 Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes DD263231A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601624A SE8601624D0 (sv) 1986-04-11 1986-04-11 New pharmaceutical preparations

Publications (1)

Publication Number Publication Date
DD263231A5 true DD263231A5 (de) 1988-12-28

Family

ID=20364135

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87301670A DD263231A5 (de) 1986-04-11 1987-04-09 Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes

Country Status (34)

Country Link
US (1) US4803081A (ja)
EP (1) EP0249587B1 (ja)
JP (1) JPH0778016B2 (ja)
KR (2) KR870009720A (ja)
CN (1) CN1025150C (ja)
AT (1) ATE76288T1 (ja)
AU (1) AU602677B2 (ja)
CA (1) CA1304294C (ja)
CS (1) CS270560B2 (ja)
CY (1) CY1826A (ja)
DD (1) DD263231A5 (ja)
DE (1) DE3779183D1 (ja)
DK (1) DK173033B1 (ja)
DZ (1) DZ1067A1 (ja)
EG (1) EG18265A (ja)
ES (1) ES2031929T3 (ja)
FI (1) FI91826C (ja)
GR (1) GR3005286T3 (ja)
HK (1) HK26795A (ja)
HU (1) HU204699B (ja)
IE (1) IE59419B1 (ja)
IS (1) IS1553B (ja)
MY (1) MY101553A (ja)
NO (1) NO174795B (ja)
NZ (1) NZ219633A (ja)
PH (1) PH22494A (ja)
PL (1) PL265078A1 (ja)
PT (1) PT84663B (ja)
SE (1) SE8601624D0 (ja)
SG (1) SG4295G (ja)
SU (1) SU1743332A3 (ja)
UA (1) UA12336A (ja)
YU (1) YU47258B (ja)
ZA (1) ZA871911B (ja)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5006344A (en) * 1989-07-10 1991-04-09 E. R. Squibb & Sons, Inc. Fosinopril tablet formulations
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
JPH07502274A (ja) * 1991-12-10 1995-03-09 ラシユ−プレスビタリアン−セントルークス・メデイカル・センター 多薬剤耐性を低下させる方法および組成物
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
ES2179829T3 (es) 1992-09-18 2003-02-01 Yamanouchi Pharma Co Ltd Preparacion de hidrogel de liberacion prolongada.
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
ES2287110T3 (es) 2000-04-11 2007-12-16 Sankyo Company, Limited Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina.
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
SE0004671D0 (sv) * 2000-12-15 2000-12-15 Amarin Dev Ab Pharmaceutical formulation
WO2002056883A1 (en) * 2001-01-18 2002-07-25 Wockhardt Limited Preparation of micron-size felodipine particles by microfluidization
CN1551770A (zh) * 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
JP2005509604A (ja) * 2001-09-28 2005-04-14 マクニール−ピーピーシー・インコーポレイテッド 菓子組成物を含む剤形
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
US6726931B2 (en) * 2002-04-08 2004-04-27 Standard Chem. & Pharm. Co., Ltd. Process for preparing oral sustained-release formulation of felodipine
WO2003084518A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
ATE407674T1 (de) 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
US20030211149A1 (en) * 2002-05-07 2003-11-13 Sherman Bernard Charles Extended release tablets comprising felodipine
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
AU2003290060A1 (en) * 2002-12-17 2004-07-09 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8987322B2 (en) * 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
SI1915137T1 (sl) * 2005-08-10 2013-12-31 Add Advanced Drug Delivery Technologies, Ltd. Pripravek z nadzorovanim sproščanjem za peroralno dajanje
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
CN101103964B (zh) * 2006-07-14 2010-09-29 海南盛科生命科学研究院 一种含有非洛地平的缓释制剂及其制备方法
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
WO2012143748A1 (en) 2011-04-20 2012-10-26 Freescale Semiconductor, Inc. Amplifiers and related integrated circuits
CN104997750B (zh) * 2015-07-30 2018-03-20 杭州康恩贝制药有限公司 一种非洛地平缓释片及其制备方法
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
CN109200026B (zh) * 2017-07-03 2021-01-05 北京四环科宝制药有限公司 一种非洛地平缓释片及其制备方法
WO2019241519A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
JPS5495721A (en) * 1978-01-11 1979-07-28 Nippon Kayaku Co Ltd Nifedipine preparation
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS58109412A (ja) * 1981-12-23 1983-06-29 Toa Eiyou Kagaku Kogyo Kk ニフエジピン固形製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Also Published As

Publication number Publication date
NO174795B (no) 1994-04-05
YU47258B (sh) 1995-01-31
YU40787A (sh) 1992-09-07
PT84663B (pt) 1989-11-30
CN1025150C (zh) 1994-06-29
NO174795C (ja) 1994-07-13
GR3005286T3 (ja) 1993-05-24
CS270560B2 (en) 1990-07-12
FI871585A (fi) 1987-10-12
SG4295G (en) 1995-06-16
FI91826B (fi) 1994-05-13
UA12336A (uk) 1996-12-25
HUT43786A (en) 1987-12-28
HK26795A (en) 1995-03-10
JPH0778016B2 (ja) 1995-08-23
SE8601624D0 (sv) 1986-04-11
DK154987D0 (da) 1987-03-26
PH22494A (en) 1988-09-12
SU1743332A3 (ru) 1992-06-23
AU7004387A (en) 1987-10-15
PT84663A (en) 1987-05-01
CS258787A2 (en) 1989-11-14
DK154987A (da) 1987-10-12
KR890001521A (ko) 1989-03-27
EP0249587B1 (en) 1992-05-20
NO871199L (no) 1987-10-12
CA1304294C (en) 1992-06-30
IS1553B (is) 1994-08-10
DE3779183D1 (de) 1992-06-25
CN87102758A (zh) 1987-10-21
IE59419B1 (en) 1994-02-23
CY1826A (en) 1995-12-01
ATE76288T1 (de) 1992-06-15
ES2031929T3 (es) 1993-01-01
EG18265A (en) 1992-12-30
HU204699B (en) 1992-02-28
FI91826C (fi) 1994-08-25
EP0249587A1 (en) 1987-12-16
NO871199D0 (no) 1987-03-23
IE870925L (en) 1987-10-11
AU602677B2 (en) 1990-10-25
KR870009720A (ko) 1987-11-30
DK173033B1 (da) 1999-11-29
FI871585A0 (fi) 1987-04-10
MY101553A (en) 1991-12-17
IS3214A7 (is) 1987-10-12
KR950002147B1 (ko) 1995-03-14
US4803081A (en) 1989-02-07
ZA871911B (en) 1987-12-30
PL265078A1 (en) 1988-07-21
JPS62242613A (ja) 1987-10-23
DZ1067A1 (fr) 2004-09-13
NZ219633A (en) 1989-11-28

Similar Documents

Publication Publication Date Title
DD263231A5 (de) Verfahren zur herstellung eines festen praeparates mit verzoegerter abgabe eines wirkstoffes
DE69910183T2 (de) Darmlösliche sprudelnde zusammensetzungen
EP0265848B1 (de) Arzneizubereitungen zur oralen Verabreichung, die als Einzeldosis 10 bis 240 mg Dihydropyridin enthalten
DE69232837T3 (de) Oxycodonhaltiges Arzneimittel mit verzögerter Wirkstoffabgabe
DE69632753T2 (de) Darifenacin enthaltende pharmazeutische Zubereitungen
DE60028384T2 (de) Propofol enthaltende anästhetische zusammensetzung zur intravenösen injektion
DE2845326C2 (de) Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
EP0311582A1 (en) Pharmaceutical preparation with extended release of a dihydropyridine and a beta-adrenoreceptor antagonist and a process for the preparation thereof
DE3500103A1 (de) Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
DD222495A5 (de) Verfahren zur herstellung einer zweiphasigen festen arzneizubereitung
DE3720757A1 (de) Dhp-manteltablette
EP0551820A1 (de) Geschmacksmaskierte pharmazeutische Mittel
DD288093A5 (de) Orales osmotisches system mit berbesserter haftwirkung der membran am kern
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
EP0240484A1 (de) Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben
DE60308828T2 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung
EP0697867B1 (de) Zubereitungen in form fester lösungen
EP0143857B1 (de) Coronartherapeutikum in Form von Weichgelatine-Kapseln
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
DE60312642T2 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
DE60200317T2 (de) Formulierung mit gesteuerter Wirkstoffabgabe enthaltend Bupropion-HCI als Wirkstoff
DE2707763A1 (de) Verwendung von vincamin zur behandlung von kreislauferkrankungen des gehirns und dazu geeignetes arzneimittel
EP0271438A2 (de) Orales osmotisches System für Metoprolol mit verbesserten Formulierungseigenschaften
EP2089006B1 (de) Galanthamin-haltiges arzneimittel mit kontrollierter freisetzung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20070410